06 December 2017
The EU’s highest court has ruled that selective distribution systems that aim to preserve products’ luxury image do not violate European antitrust law by restricting third-party online platform sales, and confirmed that platform bans are not hardcore restrictions of competition.
28 November 2017
Cyprus’ competition authority has fined oil and gas company ExxonMobil and three of its distributors after finding the companies colluded to fix resale petrol prices.
16 November 2017
A high court judge has barred the UK’s Competition and Markets Authority from relying on redacted evidence when defending its warrant to search drugmaker Concordia.
15 November 2017
Ukraine’s antitrust watchdog has fined Sanofi-Aventis Ukraine and two of its distributors for a scheme that allegedly undercut generic drugs suppliers in public tenders.
09 November 2017
The head of enforcement for the UK’s Competition and Markets Authority has said “a few bad apples” have forced the agency to use more compulsory information requests.
09 November 2017
Cornerstone Research London head Peter Davis and principal Maria Maher analyse patterns in the numbers of recent European Commission antitrust investigations – the apparent drop in cartel probes and the current flurry of investigations following the e-commerce sector inquiry.
06 November 2017
Drugmaker Concordia is fighting a search warrant that the UK’s Competition and Markets Authority obtained as part of the antitrust enforcer’s hydrocortisone pay-for-delay investigation.
25 October 2017
The European Commission has closed its investigation into complaints it received in 2011 concerning the joint venture between Honeywell and DuPont for the production of a chemical for air conditioning cars, but is still assessing a new complaint.
26 September 2017
The UK’s antitrust watchdog has highlighted possible improvements to boost competition in the price comparison website sector, and launched an enforcement investigation of an operator’s exclusivity agreements with home insurance providers.
21 September 2017
Advocate-General Henrik Øe has urged the European Court of Justice to rule in favour of a decision to fine Roche and Novartis for colluding to induce consumers to use a more expensive drug rather than a cheaper off-label alternative, and to confirm the Italian competition enforcer's finding of a by-object restriction of competition.